APA (7th ed.) Citation

Rosenblum, H. G., Hadler, S. C., Moulia, D., Shimabukuro, T. T., Su, J. R., Tepper, N. K., . . . Daley, M. F. (2021). Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021. MMWR: Morbidity & Mortality Weekly Report, 70(32), 1094. https://doi.org/10.15585/mmwr.mm7032e4

Chicago Style (17th ed.) Citation

Rosenblum, Hannah G., et al. "Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021." MMWR: Morbidity & Mortality Weekly Report 70, no. 32 (2021): 1094. https://doi.org/10.15585/mmwr.mm7032e4.

MLA (9th ed.) Citation

Rosenblum, Hannah G., et al. "Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021." MMWR: Morbidity & Mortality Weekly Report, vol. 70, no. 32, 2021, p. 1094, https://doi.org/10.15585/mmwr.mm7032e4.